---
title: "CNS Pharmaceuticals, Inc. (CNSP.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CNSP.US.md"
symbol: "CNSP.US"
name: "CNS Pharmaceuticals, Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-19T16:11:24.774Z"
locales:
  - [en](https://longbridge.com/en/quote/CNSP.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CNSP.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CNSP.US.md)
---

# CNS Pharmaceuticals, Inc. (CNSP.US)

## Company Overview

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [cnspharma.com](https://cnspharma.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.23 | 76 | - | - | - |
| PB | 54.05 | 193 | 0.44 | 0.38 | 0.28 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-14T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.69 |
| Highest Target | 10.00 |
| Lowest Target | 10.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CNSP.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CNSP.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CNSP.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CNSP.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**